BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20881839)

  • 21. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
    Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
    J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors.
    Pedeutour F; Forus A; Coindre JM; Berner JM; Nicolo G; Michiels JF; Terrier P; Ranchere-Vince D; Collin F; Myklebost O; Turc-Carel C
    Genes Chromosomes Cancer; 1999 Jan; 24(1):30-41. PubMed ID: 9892106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors.
    Miura Y; Keira Y; Ogino J; Nakanishi K; Noguchi H; Inoue T; Hasegawa T
    Pathol Int; 2012 Jan; 62(1):16-27. PubMed ID: 22192800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDM2 gene amplification correlates with ring chromosome in soft tissue tumors.
    Nilbert M; Rydholm A; Willén H; Mitelman F; Mandahl N
    Genes Chromosomes Cancer; 1994 Apr; 9(4):261-5. PubMed ID: 7519048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe.
    Willmore-Payne C; Holden J; Turner KC; Proia A; Layfield LJ
    Arch Pathol Lab Med; 2008 Jun; 132(6):952-7. PubMed ID: 18517278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.
    Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS
    Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors].
    Pedeutour F; Maire G; Sirvent N;
    Bull Cancer; 2004 Apr; 91(4):317-23. PubMed ID: 15242313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors.
    Zhang H; Erickson-Johnson M; Wang X; Oliveira JL; Nascimento AG; Sim FH; Wenger DE; Zamolyi RQ; Pannain VL; Oliveira AM
    Am J Surg Pathol; 2010 Sep; 34(9):1304-11. PubMed ID: 20679883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas.
    Hostein I; Pelmus M; Aurias A; Pedeutour F; Mathoulin-Pélissier S; Coindre JM
    J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
    Leach FS; Tokino T; Meltzer P; Burrell M; Oliner JD; Smith S; Hill DE; Sidransky D; Kinzler KW; Vogelstein B
    Cancer Res; 1993 May; 53(10 Suppl):2231-4. PubMed ID: 8387391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDM2 amplification in rod-shaped chromosomes provides clues to early stages of circularized gene amplification in liposarcoma.
    Sydow S; Piccinelli P; Mitra S; Tsagkozis P; Hesla A; B R De Mattos C; Köster J; Magnusson L; Nilsson J; Ameur A; Wardenaar R; Foijer F; Spierings D; Mertens F
    Commun Biol; 2024 May; 7(1):606. PubMed ID: 38769442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SNP genotyping of a sclerosing rhabdomyosarcoma: reveals highly aneuploid profile and a specific MDM2/HMGA2 amplification.
    Bouron-Dal Soglio D; Rougemont AL; Absi R; Barrette S; Montpetit A; Fetni R; Fournet JC
    Hum Pathol; 2009 Sep; 40(9):1347-52. PubMed ID: 19454362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
    Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
    Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas.
    Forus A; Flørenes VA; Maelandsmo GM; Fodstad O; Myklebost O
    Cancer Genet Cytogenet; 1994 Dec; 78(2):165-71. PubMed ID: 7828148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.
    Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I
    Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDM2 amplification in a primary alveolar rhabdomyosarcoma displaying a t(2;13)(q35;q14).
    Meddeb M; Valent A; Danglot G; Nguyen VC; Duverger A; Fouquet F; Terrier-Lacombe MJ; Oberlin O; Bernheim A
    Cytogenet Cell Genet; 1996; 73(4):325-30. PubMed ID: 8751388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the "missing link" between lipomas and liposarcomas?
    Italiano A; Cardot N; Dupré F; Monticelli I; Keslair F; Piche M; Mainguené C; Coindre JM; Pedeutour F
    Int J Cancer; 2007 Jul; 121(2):308-15. PubMed ID: 17372913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.
    Ito M; Barys L; O'Reilly T; Young S; Gorbatcheva B; Monahan J; Zumstein-Mecker S; Choong PF; Dickinson I; Crowe P; Hemmings C; Desai J; Thomas DM; Lisztwan J
    Clin Cancer Res; 2011 Feb; 17(3):416-26. PubMed ID: 21159888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas.
    Berner JM; Forus A; Elkahloun A; Meltzer PS; Fodstad O; Myklebost O
    Genes Chromosomes Cancer; 1996 Dec; 17(4):254-9. PubMed ID: 8946207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.